Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2013 February;104(1) > Minerva Medica 2013 February;104(1):1-21

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

  ADVANCES IN STONE DISEASES


Minerva Medica 2013 February;104(1):1-21

language: English

An update on percutaneous nephrolithotomy: lessons learned from the CROES PCNL Global Study

Tefekli A. 1, Cordeiro E. 2, De La Rosette J. J. M. C. H. 2

1 Nisantasi, Istanbul, Turkey;
2 AMC University Hospital, Amsterdam, The Netherlands


PDF  


Since its introduction in late 1970’s, percutaneous nephrolithotomy (PNL) has undergone an evolution in both equipment and technique. This evolution still continues today in the era of minimally invasive treatment options, and is evidenced by the numerous publications. PNL is generally advantageous in the management of large renal stones (>1.5-2 cm) with high stone-free rates and considerable complication rates. However this technique is especially competing with retrograde intrarenal surgery and laparoscopic techniques. Therefore the CROES Global PNL Study Group prospectively collected data of over 5800 patients managed with PNL worldwide and analyzed the data in detail, producing more than 25 scientific papers. And this update focuses on the lessons learned from the CROES PCNL Global Study.

top of page

Publication History

Cite this article as

Corresponding author e-mail

J.J.delaRosette@amc.uva.nl